Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | ABCB1 | P08183 | 15/20 | 0.53 |
| ▸ | MMP2 | P08253 | 3/20 | 0.52 |
| ▸ | MMP14 | P50281 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL862189 | 0.93 | CYP3A4 (0.59) | CYP3A4MAPK1ABCB1 | |
| SCHEMBL5359695 | 0.93 | CYP3A4 (0.59) | CYP3A4MAPK1ABCB1 | |
| SCHEMBL862107 | 0.91 | MMP2 (0.59) | CYP3A4MAPK1MMP2MMP14 | |
| SCHEMBL862370 | 0.89 | MMP2 (0.61) | CYP3A4MAPK1MMP2MMP14 | |
| SCHEMBL25246785 | 0.87 | CYP3A4 (0.78) | CYP3A4MAPK1ABCB1 | |
| SCHEMBL862416 | 0.87 | CYP3A4 (0.78) | CYP3A4MAPK1ABCB1 | |
| SCHEMBL862428 | 0.82 | MMP2 (0.53) | MMP2MMP14 | |
| SCHEMBL1973504 | 0.81 | CYP3A4 (0.80) | CYP3A4MAPK1ABCB1 | |
| Meciadanol SCHEMBL790768 | 0.81 | BACE1 (0.68) | CYP3A4MAPK1MMP2MMP14 | |
| Meciadanol SCHEMBL790769 | 0.81 | BACE1 (0.68) | CYP3A4MAPK1MMP2MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210015964-A1 | METHOD OF FORMING AND USING A HEMOSTATIC HYDROCOLLOID | UNITED HEALTH PRODUCTS INC (US) | 2021-01-21 | — | — | US | disclosed |
| US-20140046277-A1 | FAST-CLOTTING WOUND DRESSINGS | GAMMA THERAPEUTICS, INC. | 2014-02-13 | — | — | US | disclosed |
| US-8557874-B2 | Hemostatic material | EPIC WOUND CARE, INC. (US) | 2013-10-15 | — | — | US | disclosed |
| WO-2012142317-A1 | FAST-CLOTTING WOUND DRESSINGS | GAMMA THERAPEUTICS, INC (US) | 2012-10-18 | — | — | WO | disclosed |
| WO-2009070684-A2 | HEMOSTATIC MATERIAL | BAGGETT RICHARD W (US) | 2009-06-04 | — | — | WO | disclosed |
| US-20090136562-A1 | Hemostatic Material | UNITED ECOENERGY CORP. | 2009-05-28 | — | — | US | disclosed |
| WO-2009002768-A2 | LIQUID BANDAGE | MEDSPRING GROUP, INC. (US) | 2008-12-31 | — | — | WO | disclosed |
| EP-1638491-A4 | DEPLOYABLE MULTIFUNCTIONAL HEMOSTATIC AGENT | UNIV LOMA LINDA MED (US) | 2008-05-28 | — | — | EP | disclosed |
| US-20080031929-A1 | LIQUID BANDAGE | MEDSPRING GROUP, INC. | 2008-02-07 | — | — | US | disclosed |
| US-20070026052-A1 | Hemostatic material | UNITED ECOENERGY CORP. | 2007-02-01 | — | — | US | disclosed |
| EP-1638491-A2 | DEPLOYABLE MULTIFUNCTIONAL HEMOSTATIC AGENT | Loma Linda University Medical Center (US) | 2006-03-29 | — | — | EP | disclosed |
| US-20050123588-A1 | Deployable multifunctional hemostatic agent | LOMA LINDA UNIVERSITY MEDICAL CENTER | 2005-06-09 | — | — | US | disclosed |
| WO-2005002510-A2 | DEPLOYABLE MULTIFUNCTIONAL HEMOSTATIC AGENT | LOMA LINDA UNIVERSITY MEDICAL CENTER (US) | 2005-01-13 | — | — | WO | disclosed |
| US-20030044380-A1 | Adhesive including medicament | LOMA LINDA UNIVERSITY | 2003-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030044380-A1 | Adhesive including medicament | ICAM1, VCAM1, EPCAM | CYP3A4 4815/4885MAPK1 4331/4885ABCB1 520/4885 |
| US-20080031929-A1 | LIQUID BANDAGE | FGB, F2, F8 | CYP3A4 3316/4885MAPK1 4222/4885ABCB1 3964/4885 |
| US-20050123588-A1 | Deployable multifunctional hemostatic agent | FGB, CHIT1, CHIA | CYP3A4 3864/4885MAPK1 4055/4885ABCB1 4815/4885 |
| US-20070026052-A1 | Hemostatic material | F2, F8, F3 | CYP3A4 2679/4885MAPK1 4199/4885ABCB1 4279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.